Stay updated with breaking news from Checkmate Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kuros Biosciences AG / Key word(s): Half Year Results Kuros Biosciences reports results for the first six months of 2022 09-Aug-2022 / 17:50 CET/CEST Release of an ad hoc announcement pursuant to
Small-cap stocks are companies with market capitalizations of less than $2 billion. These stocks can be very volatile, and thus, could offer impressiv
We have used the April return data to come up with the five worst performing small-cap stocks in April 2022 and best performing small-cap stocks in April 2022.
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Rating) and Checkmate Pharmaceuticals (NASDAQ:CMPI – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings. Volatility & Risk Tarsus Pharmaceuticals has a beta of […]
Regeneron is moving to make an all-cash acquisition of Checkmate Pharmaceuticals worth...